Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
Bcl-2 antisense therapy in multiple myeloma.
Asher A. Chanan-Khan
Hematology / Oncology / Cancer Center / Breast Clinic
Research output
:
Contribution to journal
›
Review article
›
peer-review
22
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Bcl-2 antisense therapy in multiple myeloma.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
oblimersen
100%
Multiple Myeloma
56%
Dexamethasone
35%
Bortezomib
15%
Antineoplastic Agents
12%
Doxorubicin
11%
Therapeutics
9%
Thalidomide
7%
Phase III Clinical Trials
7%
Antisense Oligonucleotides
7%
Vincristine
6%
Biological Factors
6%
Multiple Drug Resistance
6%
Plasma Cells
6%
Randomized Controlled Trials
4%
Apoptosis
3%
Cell Line
3%
Drug Therapy
3%
Messenger RNA
3%
Proteins
2%